Leap-In Transposase
Leveraging Innovative Transposase Technology for a Highly Reliable and Productive CMC Platform
Wheeler Bio
PAO-06-24-CL-05May 30, 2024
CMC
Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform
Wheeler Bio
PAO-12-23-CL-04Feb 08, 2024
Glycosylation
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
Junyong Park
Samsung Biologics
PAO-12-23-CL-06Dec 14, 2023
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
Samsung Biologics
PR-M10-23-06Oct 24, 2023
CMC
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
Jesse McCool, Ph.D.; David Schmidt, M.B.A., M.Sc.; Oren Beske, Ph.D.; Stephen Monks, Ph.D.
Wheeler Bio
PAO-07-23-CL-05Jul 26, 2023
Consulting
Supporting Drug Development – Increasing Probability of Success
Nick Davies; Beth Lindsey; Ian Smart
Verta Life Sciences
PAO-03-23-CL-04Mar 24, 2023
Cell and Gene Therapy
State of the Cell and Gene Therapy Market
James Grote
Nice Insight
PAO-10-022-NI-01Oct 11, 2022
Cell and Gene Therapy
Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products
Jennifer Cheung
WuXi Advanced Therapies
PAO-09-21-CL-07Sep 14, 2021
Live Biotherapeutic Products
Framing the Narrative on CMC Development for Microbiome Therapeutics
Aaron B. Cowley, Ph.D.; Melanie Cerullo; Jeff Heiser
Arranta Bio
PAO-06-21-CL-05Jun 14, 2021
Chemistry, Manufacturing, and Controls
Phase-Appropriate CMC Activities Facilitate the Transition from Early Development through Commercialization
Matthew Rota; Lisa Caralli; Jim Spavins
Catalent
PAO-01-21-CL-05Feb 05, 2021